Task: Answer the multiple choice question.
Question: Which drug exhibits a -75.021% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: COC(=O)c1ccc(-c2noc(CN(Cc3ccccn3)CC3CCCO3)n2)cc1
b: Clc1nc2ccccc2cc1-c1nnn(-c2ccccc2Br)n1
c: N#CCCN(C(=O)COC(=O)CCc1c[nH]c2ccccc12)c1ccc(F)cc1
d: CC(c1ccc(F)cc1)n1c(Cn2ncc3ccccc3c2=O)n[nH]c1=S
e: COCCCNC(=O)c1cc2cc([N+](=O)[O-])cc(OC)c2oc1=O
Answer: a. COC(=O)c1ccc(-c2noc(CN(Cc3ccccn3)CC3CCCO3)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccc(-c2noc(CN(Cc3ccccn3)CC3CCCO3)n2)cc1
COC(=O)c1ccc(-c2noc(CN(Cc3ccccn3)CC3CCCO3)n2)cc1
methyl 4-[5-[[oxolan-2-ylmethyl(pyridin-2-ylmethyl)amino]methyl]-1,2,4-oxadiazol-3-yl]benzoate